MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajcp/aqad056

Медицинская библиотека · American journal of clinical pathology · 2023

HER2 in uterine serous carcinoma: Current state and clinical perspectives.

Navarro Sanchez Janira M, Finkelman Brian S, Turner Bradley M, Katerji Hani, Wang Xi, Varghese Sharlin, Wang Tiannan, Peng Yan, Hicks David G, Zhang Huina

ОбзорСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Uterine cancer has the highest incidence and the second-highest mortality rate among gynecologic malignancies in the United States. Although uterine serous carcinoma (USC) represents less than 10% of endometrial carcinomas, it accounts for a disproportionate 50% of tumor relapses and 40% of endometrial cancer deaths. Over the past decade, clinical trials have focused on finding better treatments for this aggressive subtype of endometrial cancer, especially HER2-targeted therapy.

METHODS

We conducted a literature search in PubMed to expand the understanding of HER2 in USC.

RESULTS

HER2 has been established as an important biomarker with prognostic and therapeutic implications in USC. Intratumoral heterogeneity and lateral/basolateral membranous staining of HER2 as well as high discordance between HER2 immunohistochemistry and in situ hybridization are more common in USC than in breast carcinoma. Therefore, a universal HER2 testing and scoring system more suitable to endometrial cancer is needed and currently under investigation.

CONCLUSIONS

This review discusses the clinical perspective of HER2 overexpression/gene amplification in USC, the distinct HER2 staining pattern and the evaluation of HER2 in USC, the resistance mechanisms of HER2-targeted therapy in HER2-positive cancers, and likely areas of future investigation.

Для цитирования: Navarro Sanchez Janira M, Finkelman Brian S, Turner Bradley M, Katerji Hani, Wang Xi, Varghese Sharlin, Wang Tiannan, Peng Yan, Hicks David G, Zhang Huina. HER2 in uterine serous carcinoma: Current state and clinical perspectives.. American journal of clinical pathology. 2023. DOI: 10.1093/ajcp/aqad056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.